- Home
- THAR vs SGD Comparison
THAR vs SGD Comparison
Compare THAR & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- SGD
- Stock Information
- Founded
- THAR 2017
- SGD 2021
- Country
- THAR United States
- SGD United States
- Employees
- THAR 3
- SGD N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- SGD
- Sector
- THAR Health Care
- SGD
- Exchange
- THAR Nasdaq
- SGD Nasdaq
- Market Cap
- THAR 16.8M
- SGD 4.4M
- IPO Year
- THAR 2022
- SGD N/A
- Fundamental
- Price
- THAR $3.14
- SGD $1.32
- Analyst Decision
- THAR Strong Buy
- SGD
- Analyst Count
- THAR 1
- SGD 0
- Target Price
- THAR $17.00
- SGD N/A
- AVG Volume (30 Days)
- THAR 29.4M
- SGD 1.4M
- Earning Date
- THAR 11-06-2025
- SGD 08-15-2025
- Dividend Yield
- THAR N/A
- SGD N/A
- EPS Growth
- THAR N/A
- SGD N/A
- EPS
- THAR N/A
- SGD N/A
- Revenue
- THAR N/A
- SGD $1,536,255.00
- Revenue This Year
- THAR N/A
- SGD N/A
- Revenue Next Year
- THAR N/A
- SGD N/A
- P/E Ratio
- THAR N/A
- SGD N/A
- Revenue Growth
- THAR N/A
- SGD 1570.24
- 52 Week Low
- THAR $0.95
- SGD $0.65
- 52 Week High
- THAR $9.08
- SGD $6.25
- Technical
- Relative Strength Index (RSI)
- THAR 48.05
- SGD 54.46
- Support Level
- THAR $2.75
- SGD $1.02
- Resistance Level
- THAR $3.46
- SGD $1.80
- Average True Range (ATR)
- THAR 1.23
- SGD 0.15
- MACD
- THAR -0.32
- SGD 0.02
- Stochastic Oscillator
- THAR 6.16
- SGD 49.47
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.